Carlos Lobato

511 citations
14 papers · 399 indexed · h-index 7
Topics
Prostate Cancer Treatment and Research (5 papers)Cancer, Hypoxia, and Metabolism (2 papers)Cancer, Lipids, and Metabolism (2 papers)
Partner nations
PortugalMexicoCanada

In The Last Decade

Carlos Lobato

12 papers receiving 387 citations

Peers

Carlos Lobato
Comparison fields: 5 of 71
  • Cancer Research 155
  • Pulmonary and Respiratory Medicine 137
  • Molecular Biology 129
  • Physiology 91
  • Epidemiology 66
Replace Duc‐Vinh Pham with:
Duc‐Vinh Pham South Korea
Xingwen Da China
Huifeng Jin United States
Vesna Martinović Serbia
Christine Heinzle Austria
Laura del Puerto‐Nevado Spain
Linbo Yuan China
Xiangru Zheng China
Yoshio Terao Japan
Carlos Lobato relative to Duc‐Vinh Pham South Korea Duc‐Vinh Pham's profile →
Citations per field
00.5×10×15×18.5×
Duc‐Vinh Pham · 1×
Citations per year

Countries citing papers authored by Carlos Lobato

Since Specialization
Citations

This map shows the geographic impact of Carlos Lobato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Lobato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Lobato more than expected).

Fields of papers citing papers by Carlos Lobato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Lobato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Lobato. The network helps show where Carlos Lobato may publish in the future.

Co-authorship network of co-authors of Carlos Lobato

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Lobato. A scholar is included among the top collaborators of Carlos Lobato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Lobato. Carlos Lobato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 3
2 6
3 23
4 23
5 74
6 113
7 64
8 26
9 0
10 57
11 0
12 6
13 1
14 3

About Carlos Lobato

Carlos Lobato is a scholar working on Cancer Research, Molecular Medicine and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 399 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (155 citations), Drug Discovery (1 citation) and Pulmonary and Respiratory Medicine (137 citations). Carlos Lobato has collaborated with scholars based in Portugal, Mexico and Canada. Frequent co-authors include Paulo Príncipe, Rui Medeiros, Ricardo Ribeiro, Avelino Fraga, Cátia Monteiro, Carlos Lopes, Francisco S. N. Lobo, Jorge Oliveira, Francisco Pina and Virgínia Cunha. Their work appears in journals such as Journal of Ethnopharmacology, European Journal of Cancer and BMC Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026